Home » Topics » BioWorld Science

BioWorld Science
RSS

Global Blood Therapeutics patents pyruvate kinase activators

Oct. 27, 2021

Stealth BioTherapeutics describes compounds for treating mitochondrial disease

Oct. 27, 2021

New tyrosine-protein kinase CSK inhibitors identified at Plexxikon

Oct. 27, 2021

Discovery of novel VMAT2 inhibitor with potential for the treatment of tardive dyskinesia

Oct. 27, 2021

VY-NPC101, a potential NPC1-based gene therapy strategy for Niemann-Pick disease type C

Oct. 27, 2021

Impaired axon guidance is early sign of Wolfram syndrome

Oct. 26, 2021

AstraZeneca compound shows activity against triple-mutant EGFR

Oct. 26, 2021

Tremeau to develop novel deuterium-enriched etoricoxib compound for acute pain

Oct. 26, 2021

Oxytocin receptor hypermethylation tied to obsessive-compulsive disorder

Oct. 26, 2021

Trivalent COVID-19 vaccine candidates do not require refrigeration, could be self-administered

Oct. 26, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...